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Available online 12 February 2014It is unclear whether cell culture methodology affects the corticosteroid sensitivity of chronic
obstructive pulmonary disease (COPD) alveolar macrophages. We compared the effect of a
short and a long isolation procedure on corticosteroid inhibition of lipopolysaccharide (LPS)
stimulated cytokine release from COPD alveolar macrophages. We also investigated signalling
pathways associated with macrophage activation during cell isolation. Macrophages cultured
using a short isolation protocol released higher unstimulated levels of tumour necrosis factor
(TNF)-α and chemokine C–X–C motif ligand (CXCL) 8; these macrophages were less sensitive
to corticosteroid inhibition of LPS stimulated TNF-α and CXCL8 release when compared to a
long isolation procedure. This was associated with increased p38 mitogen activated kinase
(MAPK) activation. The p38 MAPK inhibitor, BIRB-796, significantly reduced unstimulated
cytokine release. A key finding of this study was that both cell culture methods showed no
difference in the corticosteroid sensitivity between COPD and control macrophages. We conclude
that the culture of alveolarmacrophages using a short isolation procedure alters cytokine production
through p38 MAPK activation; this is associated with a change in corticosteroid sensitivity.
© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license. Keywords:
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p38 MAPK1. Introduction
Alveolar macrophages play a key role in host defence to
inhaled microbes and particulate matter (Gordon and Read,
2002). Macrophages are professional phagocytes which engulf
invading antigens while minimising tissue damage (Murray and
Wynn, 2011). These cells also regulate the immune response
through the secretion of cytokines, chemokines, and growth
factors.
COPD is characterised by an abnormal inflammatory
response to inhaled noxious particles, commonly cigarette
smoke (www.goldcopd.org). This inflammatory response
involves increased numbers of macrophages in the airwaysx: +44 161 291 5806.
k (A. Higham).
er B.V.Open access under CC BY(Hogg et al., 2004); these macrophages play a central role in
co-ordinating pulmonary inflammation, for example by the
secretion of CXCL8which is known to be increased in the lungs
of COPD patients (Keatings et al., 1996) and is a potent
neutrophil chemoattractant (Kaur and Singh, 2013).
Inhaled corticosteroids (ICS) are the first choice anti-
inflammatory treatment for COPD; these drugs improve lung
function and reduce exacerbation rates (Calverley et al., 2007).
However, many COPD patients treated with ICS have persis-
tent airway inflammation and recurrent exacerbations
(Bourbeau et al., 2007; Soriano et al., 2007). The effects of
corticosteroids have been investigated using COPD alveolar
macrophages cultured in vitro; it has been reported that
corticosteroids have a reduced effect on cytokine production
from COPD compared to control macrophages, leading to the
suggestion that COPDmacrophages have acquired corticosteroid-NC-ND license. 
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have repetitively found that the effects of corticosteroids on
cytokine production from COPD and control macrophages are
similar (Armstrong et al., 2009, 2011; Southworth et al., 2012;
Higham et al., 2013; Lea et al., 2013; Plumb et al., 2013). We also
observed that corticosteroids have a relatively limited effect on
the macrophage secretion of certain inflammatory mediators
that are centrally involved in the pathophysiology of COPD,
such as CXCL8.
Alveolarmacrophages are commonly isolated for culture by
plate adherence. The duration of plate adherence may cause
cell activation; plate adherence for 1 h results in higher levels
of spontaneous TNF-α, CXCL8, and interleukin (IL)-6 produc-
tion compared to plate adherence for 24 h (Tomlinson et al.,
2012). These results demonstrate that alveolar macrophages
show an increased level of activation soon after isolation; this
was also associated with a failure to demonstrate an incre-
mental response to subsequent LPS stimulation. Plate adher-
ence itself may be the cause of this acute cellular activation, but
the saline flushing required to retrieve macrophages from the
lungs may also cause cell activation by osmotic or mechanical
stress (Denkert et al., 1998; Aikawa et al., 2002; Shiratsuchi and
Basson, 2005). A longer duration of culture for cell isolation
appears to allow initial cell activation, due to either plate
adherence or saline flushing, to settle over time.
It appears that the activation state and LPS responsiveness of
macrophages differ according to the time of stimulation after
isolation (Tomlinson et al., 2012). This phenomenon has not
been studied in COPD alveolar macrophages. It is important to
understand whether methodological differences in protocols for
COPDmacrophage culture used in different studies could lead to
different states of cell activation that change corticosteroid
sensitivity.
The aim of this study was to investigate the effect of cell
culture methodology on the corticosteroid sensitivity of COPD
alveolar macrophages. The effect of corticosteroids on cytokine
production from unstimulated and LPS stimulated macrophages
isolated using different protocols was investigated. We also
investigated changes in cell signalling pathways during different
macrophage isolation protocols.
2. Methods
2.1. Study subjects
43 patients undergoing surgical resection for lung cancer
were recruited (Table 1). COPD was diagnosed based on
≥10 pack years smoking history, typical symptoms and airflow
obstruction. Controls were smokers (S) with normal lung
function. All subjects gave written informed consent. This
research was approved by the local research ethics committee.
2.2. Alveolar macrophage isolation
Alveolar macrophages were isolated from the lungs as
previously described (Armstrong et al., 2009). Briefly, resected
tissue was perfused with 0.1 M NaCl and the retrieved fluid
was centrifuged (10 min, 400 g, room temperature). The cell
pellet was re-suspended in RPMI-1640 media (Sigma-Aldrich,
Poole, UK), layered over Ficoll-Paque (GE Healthcare, Bucking-
hamshire, UK), and centrifuged. Alveolar macrophage numberand total cell number were assessed by trypan blue exclusion.
Alveolar macrophages were re-suspended at a density of
1 × 106 per ml in RPMI-1640 media supplemented with
10% v/v foetal calf serum (Invitrogen, Paisley, UK), 2 mM
L-glutamine (Invitrogen), 100 U/ml penicillin and 100 μg/ml
streptomycin (Sigma-Aldrich). The average number of
non-adherent cells was 1.5 × 106 per ml.
2.3. Alveolar macrophage culture
Freshly isolated macrophages were seeded onto flat bot-
tomed96-well plates at a concentration of 1 × 105macrophages
per well. There were two different culture conditions (Fig. 1);
condition 1: macrophages were rested for 1 h in a 5% CO2
humidified atmosphere at 37 °C before non-adherent cells were
removed and fresh medium was added (short incubation
protocol). Condition 2: macrophages were rested for 16 h in a
5% CO2 humidified atmosphere at 37 °C and the following day
non-adherent cells were removed and freshmediumwas added
(long incubation protocol).
After the addition of fresh media, macrophages cultured
under both conditions were cultured for a further 24 hwith and
without LPS (1 μg/ml Escherichia coli, O26:B6, Sigma-Aldrich).
Cell culture supernatants were removed and analysed for TNF-α
and CXCL8 by ELISA according to the manufacturer's instruc-
tions (R&D Systems, Abbingdon, UK).
2.3.1. The effect of dexamethasone on LPS stimulated cytokine
release
After the addition of fresh media, macrophages cultured
under both conditions (short and long incubation protocols)
were treated with dexamethasone (0.1–1000 nM) or vehicle
control (DMSO 0.005%, now referred to as “vehicle”) (both
Sigma-Aldrich) for 1 h followed by LPS (1 μg/ml) stimulation
for 24 h. Cell culture supernatants were removed and
analysed for TNF-α and CXCL8 by ELISA.
2.3.2. The effects of dexamethasone and BIRB-796 on unstimulated
cytokine release
After the addition of fresh media, macrophages cultured
under both conditions were treated with either dexametha-
sone (1 μM), the p38 MAPK inhibitor BIRB-796 (1 μM,
Sigma-Aldrich), or vehicle for 24 h (this timepoint was chosen
to match the cell culture with LPS). Cell culture supernatants
were removed and analysed for TNF-α, and CXCL8 by ELISA.
2.3.3. Phosporylation of p38 MAPK and NF-κB p65
Freshly isolated macrophages were seeded onto flat
bottomed 6-well plates at a concentration of 1 × 106
macrophages per well for experiments investigating protein
content by Western blot. Macrophages were cultured for
15 min, 30 min, 60 min (which represent the short incuba-
tion protocol and can be subdivided into 1a, 1b, and 1c
respectively) and 16 h (condition 2), prior to non-adherent
cell removal and the remaining cells were lysed. Samples
were then prepared for Western blot.
2.4. Western blot
Cells were lysed in RIPA buffer [10 mM Tris–HCl, pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.25%]
Table 1
Subject demographics. Data shown are mean (sd). S: smokers, FEV1: forced expiratory volume in 1 s, FVC: forced vital capacity, and ICS: inhaled corticosteroid.
S COPD
ELISA study 1 ELISA study 2 Western blot study ELISA study 1 ELISA study 2 Western blot study
n 9 8 4 10 8 4
GOLD stage I n/a n/a n/a 3 2 3
GOLD stage II n/a n/a n/a 6 5 1
GOLD stage III n/a n/a n/a 1 1 0
Age (yrs) 69.6 (5.5) 67.9 (10.7) 69.8 (8.5) 68.4 (6.2) 68.5 (8.1) 67.3 (6.1)
Sex (M/F) 4/5 3/5 4/0 6/4 5/3 2/2
FEV1 (L) 2.3 (0.5) 1.9 (0.2) 2.8 (0.4) 1.8 (0.5) 1.8 (0.6) 2.0 (0.9)
FEV1 % predicted 100.9 (18.1) 86.5 (9.1) 110.5 (37.7) 71.5 (15.1) 65.4 (16.1) 85.5 (13.8)
FVC (L) 3.1 (0.6) 2.6 (0.3) 3.9 (0.7) 3.0 (0.6) 3.3 (0.6) 4.0 (1.9)
FEV1/FVC ratio (%) 75.1 (5.7) 82.2 (12.4) 72.4 (8.6) 61.1 (7.9) 55.2 (16.3) 49.4 (5.9)
Pack year history 36.3 (26.3) 46.4 (17.3) 20.7 (5.0) 64.7 (37.2) 48.3 (30) 45.3 (29.4)
Current/ex-smoker 3/6 5/3 2/2 6/4 6/2 2/2
ICS users 0 0 0 4 4 0
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hibitors (Calbiochem, Nottingham, UK). Cell lysates diluted
in sample buffer [62.5 mM Tris, 10% glycerol, 1% SDS, 1%
β-mercaptoethanol, and 0.01% bromphenol blue, pH 6.8]
were electrophoresed on SDS polyacrylamide gels (10%)
and transferred to Hy-bond ECL membranes (Whatman
International Ltd, Kent, UK). Membranes were incubated
with blocking buffer [5% dried milk in Tris buffered saline
containing 0.1% Tween 20 (TBS/Tween 20)] for 1 h at room
temperature and then incubated with primary antibodies
(diluted in blocking buffer) at 4 °C overnight (rabbit anti-
phospho-p38 MAPK [Thr180/Tyr182], rabbit anti-phospho-
NF-κB p65 [Ser536]; Cell Signalling, Hertfordshire, UK, and
rabbit anti-β-actin, Abcam, Cambridge, UK). After washing
in TBS/Tween 20, the membranes were incubated for 60 min
with a peroxidase-conjugated secondary antibody (diluted
in wash buffer) (horseradish peroxidase-conjugated goat
anti-rabbit, Cell Signalling), washed again, and the antibody-
labelled proteins were visualized by enhanced chemilumi-
nescence (Amersham Biosciences, Buckinghamshire, UK).
Densitometric analysis was performed by normalising band
density to that for β-actin using Quantity One v4.6.1
software (Bio-Rad, Hertfordshire, UK).
2.5. Data analysis
All statistical analysis was performed using GraphPad
InStat software (GraphPad Software Inc., La Jolla, California,
USA). Unstimulated CXCL8 release, and LPS stimulated TNF-α
and CXCL8 release were normally distributed and therefore
compared using a repeated measures ANOVA followed by a
paired t-test. Dexamethasone dose response curves were
compared using a repeated measures ANOVA followed by a
Bonferonni post-test. Unstimulated TNF-α release was
not-normally distributed and therefore compared using a
Friedman test followed by a Wilcoxon matched pairs test.
p b 0.05 was considered significant.
3. Results
3.1. Supernatant cytokine secretion
Alveolar macrophages isolated from 10 COPD patients and
9 S were used for the following experiments.3.1.1. Unstimulated cytokine release
Alveolar macrophages isolated under condition 1 (1 h
culture for adherence and isolation) and condition 2 (16 h
culture for adherence and isolation)were then cultured for 24 h;
supernatant TNF-α and CXCL8 levels under condition 1 were
significantly higher (p b 0.001 for all comparisons) compared to
condition 2, in both COPD patients and S (Fig. 2). COPD alveolar
macrophages cultured under condition 1 had significantly lower
levels of CXCL8 compared to S (p = 0.02), but there were no
differences for CXCL8 between groups under condition 2. There
were no differences between groups for TNF-α.
3.1.2. LPS stimulated cytokine release
Alveolar macrophages isolated under conditions 1 and 2
were stimulated with LPS for 24 h (Fig. 3). LPS stimulation
increased TNF-α and CXCL8 production under both condi-
tions above matched unstimulated controls. COPD alveolar
macrophages produced similar TNF-α levels when comparing
conditions 1 and 2 (Fig. 3), while TNF-α production from S
alveolar macrophages was significantly higher from condition
1 when compared to condition 2 (p = 0.03). TNF-α produc-
tion from COPD alveolar macrophages cultured under
conditions 1 and 2 was significantly lower than S alveolar
macrophages (p = 0.048 and p = 0.04 respectively).
There were no differences observed in the levels of LPS
stimulated CXCL8 when comparing conditions 1 and 2
(Fig. 3). There were also no differences when comparing
COPD patients to S.
3.1.3. Dexamethasone inhibition of LPS stimulated cytokine
release
Alveolarmacrophages isolatedunder conditions 1 and2were
subsequently cultured with dexamethasone (0.1–1000 nM) for
1 h followed by LPS stimulation for 24 h. TNF-α and CXCL8
production from both COPD and S alveolar macrophages was
significantly inhibited by dexamethasone. However, the level of
TNF-α and CXCL8 inhibition in both COPD and S alveolar
macrophages cultured under condition 2was significantly higher
than condition 1 (at concentrations 1–1000 nM for TNF-α and
10–1000 nM for CXCL8; Figs. 4 and 5 respectively). The effects of
dexamethasone on TNF-α and CXCL8 productionwere similar in
COPD patients compared to S; although there was a numerically
greater effect of dexamethasone at some concentrations, these
differences were not statistically significant e.g. at 1000 nM
Fig. 1. A schematic representation of short (condition 1) and long (condition 2) incubation protocols used to isolate alveolar macrophages.
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17% and 21% (conditions 1 and 2 respectively; p N 0.05), while
the mean difference for CXCL8 inhibition was 20% and 18% for
CXCL8 (conditions 1 and 2 respectively; p N 0.05).3.2. Activation of p38 MAPK and NF-κB p65
We hypothesised that the increased unstimulated release of
TNF-α and CXCL8 from alveolar macrophages cultured under
condition 1may be due to increased activation of the p38MAPK
or NF-κB pathways. The reduced effects of dexamethasone
may also be due to activation of these pathways. Alveolar
macrophages from 4 COPD patients and 4 S were cultured for
15 min, 30 min, 60 min (conditions 1a, 1b, and 1c respectively),
and 16 h (condition 2).0
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window of activation was not missed. Likewise, the 16 h time
point reflects the point at which pathway activation can be
observed following the long incubation protocol before the
addition of stimulants or drugs.
The levels of phosphorylated p38 MAPK were signifi-
cantly higher in COPD macrophages cultured for 15 and
30 min compared to macrophages cultured for 16 h (p =
0.03 and p = 0.02 respectively; Fig. 6). There was a
numerical trend for increased p38 MAPK activation in
macrophages cultured for 60 min compared to 16 h, but
this did not reach statistical significance (p = 0.1). Similar-
ly, the levels of phosphorylated p38 MAPK were statistically0
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Fig. 5. The effect of alternative culture conditions on dexamethasone inhibition of LPS stimulated CXCL8 release. Macrophages from smoking controls (A and C;
n = 9) and COPD patients (B and D; n = 10) were cultured under condition 1 (white bar) or condition 2 (grey bar), pre-treated with vehicle control (0.005%
DMSO) or dexamethasone (0.1–1000 nM) for 1 h before being stimulated with LPS (1 μg/ml) for 24 h. Culture supernatants were analysed for CXCL8. Data
shown are mean ± SEM of absolute CXCL8 levels (A and B) or percentage inhibition of CXCL8 (C and D). * and ** = significant mediator reduction below vehicle
control (p b 0.05 and p b 0.01 respectively) (A and B) or significantly higher level of inhibition compared to respective dexamethasone concentration under
condition 1 (C and D).
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to 16 h (p = 0.03), with numerical trends evident in
macrophages cultured for 30 and 60 min that did not
reach statistical significance compared to 16 h (p = 0.3 and
p = 0.2 respectively).
There was no difference due to the duration of cell culture
in the levels of phosphorylated NF-κB p65 in COPD or S
macrophages (Fig. 7).
3.3. Dexamethasone and BIRB-796 inhibition of unstimulated
cytokine release
Having observed that p38 MAPK activation occurs in
unstimulated cells isolated using condition 1, we investigated
whether p38 MAPK activation contributes to increased
unstimulated TNF-α and CXCL8 release by using BIRB-796, a
p38 MAPK inhibitor. Alveolar macrophages from 8 COPD
patients and 8 S were isolated using conditions 1 and 2, and
then cultured with dexamethasone (1 μM), BIRB-796 (1 μM),
or vehicle control for 24 h.
The levels of TNF-α released from macrophages cultured
under condition 2 were below the lower limit of detection of
the ELISA. The release of TNF-α from COPD and Smacrophagescultured under condition 1was inhibited by BIRB-796, with the
effect of this p38 MAPK inhibitor being greater than dexa-
methasone in both COPD and S macrophages (p = 0.0004 and
p = 0.002 respectively; Fig. 8).
The levels of CXCL8 were quantifiable from macrophages
cultured under both conditions, and were significantly
inhibited by dexamethasone and BIRB-796 (Fig. 9). The
effects of dexamethasone on CXCL8 inhibition were greater
than BIRB-796 in COPDmacrophages cultured under condition
2 (p = 0.03) but these drugs had similar effects under
condition 1 (Fig. 9). There was no difference between BIRB-796
and dexamethasone on CXCL8 production from S macrophages
cultured under conditions 1 and 2. There was no difference in
the level of inhibition of TNF-α and CXCL8 when comparing
COPD patients to S.
4. Discussion
The isolation of alveolar macrophages from COPD patients
and S using a short incubation time (1 h) resulted in significantly
different cytokine production and corticosteroid sensitivity
compared to a long incubation time (16 h). Short isolation
times caused higher unstimulated levels of TNF-α and CXCL8
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These findings were associated with increased p38 MAPK
activation with a short isolation protocol. It appears that p38
MAPK activation occurs immediately upon isolation, and that
short isolation protocols result in p38MAPK dependent cytokine
production that is associated with corticosteroid insensitivity.
The increased levels of phosphorylated p38 MAPK after a
short isolation time may be due to mechanical or osmotic
stress (Denkert et al., 1998; Aikawa et al., 2002; Shiratsuchi
and Basson, 2005) that occurs during the isolation process.Phospho-p65
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immunohistochemistry studies have shown that alveolar
macrophages in lung tissue sections from COPD patients have
elevated levels of phosphorylated p38 MAPK compared to
controls (Renda et al., 2008; Gaffey et al., 2013). Our view is
that the short isolation procedure caused p38 MAPK activationB
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reduction in TNF-α levels compared to vehicle control (A and B) (p b 0.01). ** and *** = significantly higher level of inhibition (C and D) (p b 0.01 and p b 0.001
respectively).
151A. Higham et al. / Journal of Immunological Methods 405 (2014) 144–153due to mechanical and osmotic stress, but a degree of p38
MAPK activation was probably also present because of the in
vivo pulmonary environment in COPD.
Activation of the p38 MAPK pathway promotes inflam-
mation through increasing inflammatory gene expression,
stabilising mRNAs, and enhancing protein translation
(Saklatvala, 2004). However, this pathway is corticosteroid
insensitive in alveolar macrophages; it has been reported
that corticosteroids do not inhibit phosphorylation of p38
MAPK or its downstream target, heat shock protein 27, in
LPS stimulated alveolar macrophages of COPD patients and
controls (Armstrong et al., 2011). In addition, administration
of prednisolone to COPD patients did not suppress p38
MAPK activation in whole blood cultured ex-vivo (Singh et
al., 2010). The increased activation of p38 MAPK in freshly
isolated macrophages may therefore explain reduced cortico-
steroid inhibition of LPS stimulated TNF-α and CXCL8 observed
using condition 1; the longer thesemacrophages were “rested”
in cell culture, the phosphorylated levels of p38MAPK reduced,
and corticosteroid sensitivity increased.
Increased activation of the p38 MAPK pathway may also
explain the increased unstimulated release of TNF-α and CXCL8
from macrophages isolated with a short incubation time.
BIRB-796 reduced unstimulated TNF-α and CXCL8 release by
approximately 80% and 70% respectively, confirming the p38
MAPK dependency of unstimulated cytokine production. Inter-
estingly, under condition 1 the effect of BIRB-796 was greater
than dexamethasone on TNF-α production, and equal to
dexamethasone on CXCL8 production. This furtherdemonstrates the important role of p38MAPK activation during
condition 1.
It has previously been demonstrated that COPD macro-
phages display progressive downregulation of classically acti-
vated (M1) genes including CXCL9, CXCL10, CXCL11 and IL-1β,
and progressive upregulation of alternatively activated (M2)
genes such as matrix metalloproteinase (MMP) 2 and MMP7
compared to S (Shaykhiev et al., 2009). Classically activated
macrophages are known to bemore pro-inflammatory,whereas
alternatively polarised macrophages are known to have greater
anti-inflammatory and tissue repair functions (Gordon, 2003;
Gordon and Taylor, 2005; Martinez et al., 2009). Consequently, a
reduced LPS stimulated pro-inflammatory response of COPD
alveolar macrophages compared to controls has also been
previously reported. Similarly, here we report that LPS stimulated
TNF-α production from COPD alveolarmacrophageswas reduced
compared to S, although there was no difference for CXCL8.
TNF-α release from LPS stimulated S macrophages cultured
under condition 1was higher than frommacrophages cultured
under condition 2. A probable explanation for this is the
increased p38 MAPK activation during condition 1. TNF-α
release from LPS stimulated COPD alveolar macrophages was
similar when comparing culture conditions; this may be due to
the blunted TNF-α response observed in COPD patients
compared to S, with a lower window to detect differences
between cell culture conditions.
There was no difference in the corticosteroid sensitivity of
alveolar macrophages when comparing COPD patients and S,
supporting our previous observations. Despite earlier studies
A B
C D
0
50000
100000
150000
200000
250000
Condition 1 Condition 2
*
*
*
*CX
CL
8 
(p
g/m
l)
0
50000
100000
150000
200000
250000
Condition 1 Condition 2
**
** Vehicle
Dex
Birb
*
*
CX
CL
8 
(p
g/m
l)
Dex Birb Dex Birb
0
20
40
60
80
100
Condition 1 Condition 2
%
 C
XC
L8
 in
hi
bi
tio
n
Dex Birb Dex Birb
0
20
40
60
80
100
Condition 1 Condition 2
*
%
 C
XC
L8
 in
hi
bi
tio
n
Fig. 9. The effect of dexamethasone and BIRB-796 on unstimulated CXCL8 release. Macrophages from smoking controls (n = 8; A and C) and COPD patients (n = 8;
B and D) were cultured under condition 1 or 2 and then pre-treated with vehicle (DMSO 0.005%), dexamethasone (1 μM), or BIRB-796 (1 μM) for 24 h. Culture
supernatants were analysed for CXCL8. Data shown are mean ± SEM of absolute CXCL8 levels or percentage inhibition of CXCL8. * and ** = significant reduction in
CXCL8 levels compared to vehicle control (A and B) (p b 0.01). * = significantly higher level of inhibition (C) (p b 0.05 and p b 0.01 respectively).
152 A. Higham et al. / Journal of Immunological Methods 405 (2014) 144–153proposing reduced corticosteroid sensitivity of COPD macro-
phages compared to controls (Culpitt et al., 2003; Cosio et al.,
2004), we have consistently shown that the degree of
corticosteroid inhibition of LPS stimulated cytokine production
does not differ between macrophages from COPD patients and
controls (Armstrong et al., 2009, 2011; Southworth et al., 2012;
Higham et al., 2013; Lea et al., 2013; Plumb et al., 2013). In
addition, Plumb et al. reported that glucocorticoid receptor (GR)
function, examined by GR phosphorylation and transactivation
in response to beclomethasone-17-monopropionate (17-BMP),
is similar in macrophages from COPD patients and controls. We
also confirm previous observations that LPS stimulated CXCL8
production is less sensitive to corticosteroid inhibition than
other cytokines. Corticosteroid sensitivity is regulated by an
innate transcriptional programme which is dependent on the
stimulating signal and varies between inflammatory genes.
Ogawa et al. reported that dexamethasone suppressed only
approximately half of all LPS induced genes in healthy murine
macrophages (Ogawa et al., 2005). This demonstrates the innate
restrictions on corticosteroid inhibition, and probably explains
the natural variations in the effects of corticosteroids between
different inflammatory proteins secreted by COPD alveolar
macrophages.
In conclusion, we have shown that the protocols used to
isolate and culture alveolar macrophages from COPD patients
and S can alter cytokine production through p38 MAPKactivation, which is associated with a change in corticosteroid
sensitivity after LPS stimulation. We believe these results
reflect a change in macrophage activation due to the isolation
procedure. However, the removal of non-adherent cells may
also influence macrophage behaviour in cell culture and the
study of both populations would be informative. Neverthe-
less, both cell culture methods showed no difference in
corticosteroid sensitivity between COPD and control macro-
phages, in agreement with recent publications (Higham et al.,
2013; Lea et al., 2013; Plumb et al., 2013). Our results
highlight the importance of using consistent cell culture
conditions in such experiments: different protocols can
change corticosteroid sensitivity.
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